In addition, we observed differences in the levels of FGFR2 mRNA expression between fibroblasts derived from normal breast tissue or from tumor tissue, which strongly supports a holistic model to explain FGFR2-related breast cancer risk [45] rather than one assuming cell autonomous effects of FGFR2 expression modulation. The gene discussed is FGFR2; the disease is breast cancer.